umangtalking Profile Banner
Umang Swami Profile
Umang Swami

@umangtalking

Followers
994
Following
6K
Media
35
Statuses
2K

Oncologist with focus on GU cancers and melanoma. Views my own. Following or RT≠endorsement

Salt Lake City, UT
Joined February 2014
Don't wanna be here? Send us removal request.
@umangtalking
Umang Swami
3 years
Just in @CCR_AACR: Happy to report👉SPOP mutation as 1st treatment selection biomarker in mCSPC #ProstateCancer , predicts response to ARAT & not to docetaxel @neerajaiims @EAntonarakis @RyonGraff @geoff_oxnard @OncoAlert @PCF_Science Tweetorial (1/10)
Tweet media one
Tweet media two
Tweet media three
12
101
278
@umangtalking
Umang Swami
7 days
RT @ASCO: 🎙 @neerajaiims of @huntsmancancer and Dr. Jeanny Aragon-Ching of @InovaSchar highlight key innovations in GU cancer research from….
0
19
0
@umangtalking
Umang Swami
9 days
RT @tompowles1: With the final analysis of the last of the 1st line metastatic clear cell RCC trials combination trials it’s still fair to….
0
71
0
@umangtalking
Umang Swami
12 days
RT @CrickeTendulkar: Sachin Tendulkar talks about how he came up with his famous. " upper cut ". @sachin_rt - The First OG 360° Player 🐐….
0
234
0
@umangtalking
Umang Swami
12 days
RT @helops79: Another great @AACI_Cancer meeting in the books! Always energizing to connect with colleagues and partners from across the co….
0
2
0
@umangtalking
Umang Swami
13 days
RT @cdanicas: 🥲🥲 He reported the first preclinical study on the management of cisplatin using massive prehydration and mannitol induced osm….
0
10
0
@umangtalking
Umang Swami
13 days
RT @urotoday: Real-world treatment delays between lutetium-177 and cabazitaxel in advanced #ProstateCancer. @YeonjungJoHCI & @umangtalking….
0
4
0
@umangtalking
Umang Swami
16 days
RT @urotoday: Real-world treatment patterns in #mHSPC in the US. @umangtalking and @neerajaiims @huntsmancancer discuss encouraging finding….
0
2
0
@umangtalking
Umang Swami
18 days
RT @davidrliu: A preprint from @nataliyakosmyna and coworkers reports EEG evidence that writing using LLMs reduces neural connectivity and….
0
28
0
@umangtalking
Umang Swami
20 days
RT @APCCC_Lugano: Association of Homologous Recombination Repair Alterations With Outcomes in Patients with Metastatic Hormone-Sensitive Pr….
0
16
0
@umangtalking
Umang Swami
21 days
RT @chadihcmd: Excited to see our work published in @CCR_AACR ! Real-world pts w/ mHSPC #prostatecancer w/ HRRalt had worse survival than t….
0
23
0
@umangtalking
Umang Swami
21 days
RT @neerajaiims: Just in @CCR_AACR 👉Congrats @chadihcmd @umangtalking & @Huntsman_GU team👉Poor outcomes w/ SOC Rx in mHSPC #prostatecancer ….
0
46
0
@umangtalking
Umang Swami
26 days
RT @huntsmancancer: Our researchers made a strong showing at #ASCO25 —sharing bold ideas, breakthrough science, and real-world insights to….
0
4
0
@umangtalking
Umang Swami
28 days
RT @EricTopol: The American Heart Association just published their alcohol recommendations today which line up with the report by the Natio….
0
288
0
@umangtalking
Umang Swami
29 days
RT @mufaddal_vohra: The luckiest batter in the world while batting on 98*. 😄
0
677
0
@umangtalking
Umang Swami
29 days
RT @marklewismd: When you’re at a Vegas pool party but don’t want anyone to mistake you for an extrovert
Tweet media one
0
7
0
@umangtalking
Umang Swami
29 days
RT @Axiom_Space: Representing India, meet #Ax4 Mission Pilot Shubhanshu Shukla. @isro
0
945
0
@umangtalking
Umang Swami
29 days
RT @urotoday: Talazoparib and enzalutamide in unselected #mCRPC patients. @neerajaiims @huntsmancancer joins Oliver Sartor, MD @MayoClinic….
0
3
0
@umangtalking
Umang Swami
1 month
RT @marklewismd: Just got “accept without revisions” from Reviewer #2
Tweet media one
0
35
0
@umangtalking
Umang Swami
1 month
RT @neerajaiims: Stellar presentation @ASCO #ASCO25 by trailblazer @DrRanaMcKay on ETCTN trial with radium +|- olaparib in mCRPC #prostatec….
0
22
0
@umangtalking
Umang Swami
1 month
RT @Aiims1742: Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but ra….
0
66
0